Skip to main content

and
  1. Article

    Open Access

    Identification of lysosome‐targeting drugs with anti‐inflammatory activity as potential invasion inhibitors of treatment resistant HER2 positive cancers

    Most HER2 positive invasive cancers are either intrinsic non-responsive or develop resistance when treated with 1st line HER2 targeting drugs. Both 1st and 2nd line treatments of HER2 positive cancers are aime...

    Malene Bredahl Hansen, Maria Postol, Siri Tvingsholm in Cellular Oncology (2021)

  2. No Access

    Article

    Release of transcriptional repression via ErbB2-induced, SUMO-directed phosphorylation of myeloid zinc finger-1 serine 27 activates lysosome redistribution and invasion

    HER2/ErbB2 activation turns on transcriptional processes that induce local invasion and lead to systemic metastasis. The early transcriptional changes needed for ErbB2-induced invasion are poorly understood. H...

    Ditte Marie Brix, Siri Amanda Tvingsholm, Malene Bredahl Hansen in Oncogene (2019)

  3. Article

    Open Access

    Let-7 microRNA controls invasion-promoting lysosomal changes via the oncogenic transcription factor myeloid zinc finger-1

    Cancer cells utilize lysosomes for invasion and metastasis. Myeloid Zinc Finger1 (MZF1) is an ErbB2-responsive transcription factor that promotes invasion of breast cancer cells via upregulation of lysosomal c...

    Siri Amanda Tvingsholm, Malene Bredahl Hansen in Oncogenesis (2018)

  4. Article

    Open Access

    The role of GAGE cancer/testis antigen in metastasis: the jury is still out

    GAGE cancer/testis antigens are frequently expressed in various types of malignancies and represent attractive targets for immunotherapy, however their role in cancer initiation and progression has remained el...

    Morten Frier Gjerstorff, Mikkel Green Terp, Malene Bredahl Hansen in BMC Cancer (2016)